Other studies have revealed that miR-122 is a tumor suppressor through modulating oncogenes including CDK4, cyclin G1, and AKT3 in hepatocellular carcinoma (HCC) (Nassirpour et al., 2013). This evidence concerns the gene AKT3 and hepatocellular carcinoma.